FRAMINGHAM (10/22/2003) - Incyte Corp. president and chief scientific officer Robert Stein has resigned from Incyte to become president of Roche Palo Alto LLC. Stein succeeds James N. Woody, who is leaving Roche after seven years in his current position. Incyte also announced that Richard Levy has joined the company as senior vice president of drug development, and GlaxoSmithKline's John A. Keller has taken the newly created position of executive vice president and chief business officer.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.